CompletedNot Applicable

Retrolaminar Block Versus Intraperitoneal Block for Laparoscopic Cholecystectomy

Egypt60 participantsStarted 2023-05-21

Plain-language summary

Although laparoscopic cholecystectomy is a minimally invasive surgery, it causes moderate-severe pain. The aim of this study is to assess the quality of pain relief in patients who will undergo in laparoscopic cholecystectomy surgery receiving either retrolaminar block or peritoneal block by comparing and evaluating the differences between the two techniques. It is hypothesized that retrolaminar block will be comparable to peritoneal block as a promising effective alternative for analgesia for in laparoscopic cholecystectomy surgeries with fewer side effects.

Who can participate

Age range18 Years – 65 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * American Society of Anesthesiology (ASA) 1 or 2 patients. * Scheduled for laparoscopic cholecystectomy Exclusion Criteria: * Patient's refusal. * Altered mental status or un-cooperative patients. * History of known sensitivity to the used anesthetics. * Bleeding or coagulation diathesis. * Infection or redness at the injection site. * Significant cardiac dysfunction, hepatic, or renal impairment

What they're measuring

First analgesic request

Timeframe: [Time Frame: Up to 24 hours after the procedure]

Trial details

NCT IDNCT05755815

SponsorMansoura University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-02-20

View on ClinicalTrials.gov More Laparoscopic Cholecystectomy trials